A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa

Clinical trial NCT06628947 · RECRUITING

Trial details

NCT number: NCT06628947
Sponsor: Kiora Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Retinitis Pigmentosa

Start date: 2025-08-29
Primary completion: 2027-08-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.